| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1039422835 |
| P356 | DOI | 10.1186/1475-2891-10-102 |
| P932 | PMC publication ID | 3200167 |
| P698 | PubMed publication ID | 21962075 |
| P5875 | ResearchGate publication ID | 51684182 |
| P50 | author | Lina S. Balluz | Q110552423 |
| P2093 | author name string | Kurt J Greenlund | |
| Chaoyang Li | |||
| Earl S Ford | |||
| Guixiang Zhao | |||
| Janet B Croft | |||
| P2860 | cites work | The PHQ-9: validity of a brief depression severity measure | Q24550620 |
| Is low folate a risk factor for depression? A meta-analysis and exploration of heterogeneity | Q24642035 | ||
| High vitamin B12 level and good treatment outcome may be associated in major depressive disorder | Q24805416 | ||
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Treatment of depression: time to consider folic acid and vitamin B12 | Q28304306 | ||
| Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults | Q28384473 | ||
| Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 | ||
| Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. | Q30949867 | ||
| The sex-specific role of plasma folate in mediating the association of dietary quality with depressive symptoms | Q33592297 | ||
| Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials | Q33980006 | ||
| Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time | Q33994329 | ||
| Vitamin B6 level is associated with symptoms of depression | Q34358325 | ||
| Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine | Q34449097 | ||
| Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study | Q34529325 | ||
| Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). | Q34535835 | ||
| Homocysteine and depression in later life | Q34599708 | ||
| Association between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study | Q34603727 | ||
| Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone? | Q34723758 | ||
| Homocysteine, folate, methylation, and monoamine metabolism in depression | Q35458595 | ||
| The homocysteine hypothesis of depression | Q36836495 | ||
| The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases | Q37027534 | ||
| Folate and unipolar depression | Q37120679 | ||
| The methylation, neurotransmitter, and antioxidant connections between folate and depression | Q37307834 | ||
| Public health surveillance for behavioral risk factors in a changing environment. Recommendations from the Behavioral Risk Factor Surveillance Team. | Q40579938 | ||
| Folate, B12, and life course of depressive illness | Q41308374 | ||
| Mental health literacy, folic acid and vitamin B12, and physical activity for the prevention of depression in older adults: randomised controlled trial | Q42997549 | ||
| Serum folate and homocysteine and depressive symptoms among Japanese men and women | Q43189254 | ||
| Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression | Q44015738 | ||
| Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification | Q44019931 | ||
| Depressive symptoms as relative and attributable risk factors for first-onset major depression | Q44274354 | ||
| Dietary supplement use and medical conditions: the VITAL study | Q44294218 | ||
| Depression and folate status in the US Population | Q44324897 | ||
| Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study | Q44440452 | ||
| Red cell folate concentrations in psychiatric patients | Q44461323 | ||
| Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study | Q44471450 | ||
| Prediction of treatment response in geriatric depression from baseline folate level: interaction with an SSRI or a tricyclic antidepressant | Q44491713 | ||
| Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population | Q44577695 | ||
| Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depression | Q45026425 | ||
| Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 2: predictors of relapse during the continuation phase of pharmacotherapy | Q45026428 | ||
| Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study | Q45103385 | ||
| Diabetes and anxiety in US adults: findings from the 2006 Behavioral Risk Factor Surveillance System | Q45336278 | ||
| Blood homocysteine and risk of depression in the elderly. | Q45914492 | ||
| Folate, vitamin B12, homocysteine, and depressive symptoms in a population sample of older Chinese adults. | Q45988411 | ||
| Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample | Q46459790 | ||
| The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. | Q46475910 | ||
| Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression | Q46672380 | ||
| The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults | Q46740731 | ||
| Vitamin B12 and folate serum levels in newly admitted psychiatric patients | Q46745256 | ||
| Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems. | Q46851194 | ||
| Association of folate intake with the occurrence of depressive episodes in middle-aged French men and women | Q46863630 | ||
| Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults | Q46864646 | ||
| Augmenting antidepressants with folate: a clinical perspective | Q46978274 | ||
| Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. | Q50767614 | ||
| Depression and anxiety among US adults: associations with body mass index. | Q51857316 | ||
| Oral 5'-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. | Q52038378 | ||
| Folate, vitamin B12, and homocysteine in major depressive disorder. | Q55066928 | ||
| A Comparison of National Estimates From the National Health Interview Survey and the Behavioral Risk Factor Surveillance System | Q56698287 | ||
| The PHQ-9 as a brief assessment of lifetime major depression | Q58809835 | ||
| Serum and red blood cell folate in depression | Q69688922 | ||
| Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial | Q74249043 | ||
| Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population | Q79827308 | ||
| Association between depressive symptoms and serum concentrations of homocysteine in men: a population study | Q81111184 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | folic acid | Q127060 |
| P304 | page(s) | 102 | |
| P577 | publication date | 2011-09-30 | |
| P1433 | published in | Nutrition Journal | Q15751205 |
| P1476 | title | Use of folic acid and vitamin supplementation among adults with depression and anxiety: a cross-sectional, population-based survey | |
| P478 | volume | 10 |
Search more.